170 related articles for article (PubMed ID: 11956624)
1. New attempt of preoperative differential diagnosis of thyroid neoplasms by telomerase activity measurement.
Suzuki S; Fukushima T; Ami H; Onogi H; Nakamura I; Takenoshita S
Oncol Rep; 2002; 9(3):539-44. PubMed ID: 11956624
[TBL] [Abstract][Full Text] [Related]
2. Telomerase activity in "suspicious" thyroid cytology.
Lerma E; Mora J
Cancer; 2005 Dec; 105(6):492-7. PubMed ID: 16104043
[TBL] [Abstract][Full Text] [Related]
3. Telomerase activity: a marker to distinguish follicular thyroid adenoma from carcinoma.
Umbricht CB; Saji M; Westra WH; Udelsman R; Zeiger MA; Sukumar S
Cancer Res; 1997 Jun; 57(11):2144-7. PubMed ID: 9187112
[TBL] [Abstract][Full Text] [Related]
4. Telomerase activity in fine needle aspiration biopsy samples: application to diagnosis of human thyroid carcinoma.
Guerra LN; Miler EA; Moiguer S; Karner M; Orlandi AM; Fideleff H; Burdman JA
Clin Chim Acta; 2006 Aug; 370(1-2):180-4. PubMed ID: 16600201
[TBL] [Abstract][Full Text] [Related]
5. Expression of telomerase genes in thyroid carcinoma.
Hoang-Vu C; Boltze C; Gimm O; Poremba C; Dockhorn-Dworniczak B; Köhrle J; Rath FW; Dralle H
Int J Oncol; 2002 Aug; 21(2):265-72. PubMed ID: 12118320
[TBL] [Abstract][Full Text] [Related]
6. Telomerase activity and telomere length in thyroid neoplasia: biological and clinical implications.
Matthews P; Jones CJ; Skinner J; Haughton M; de Micco C; Wynford-Thomas D
J Pathol; 2001 Jun; 194(2):183-93. PubMed ID: 11400147
[TBL] [Abstract][Full Text] [Related]
7. Quantitative analysis of telomerase activity: a potential diagnostic tool for colorectal carcinoma.
Abe N; Watanabe T; Nakashima M; Masaki T; Mori T; Sugiyama M; Atomi Y
Hepatogastroenterology; 2001; 48(39):692-5. PubMed ID: 11462905
[TBL] [Abstract][Full Text] [Related]
8. Telomerase activity in benign and malignant thyroid tumors.
Haugen BR; Nawaz S; Markham N; Hashizumi T; Shroyer AL; Werness B; Shroyer KR
Thyroid; 1997 Jun; 7(3):337-42. PubMed ID: 9226200
[TBL] [Abstract][Full Text] [Related]
9. Telomerase activity in thyroid neoplasms evaluated by the expression of human telomerase reverse transcriptase (hTERT).
Ito Y; Yoshida H; Tomoda C; Uruno T; Takamura Y; Miya A; Kobayashi K; Matsuzuka F; Kuma K; Miyauchi A
Anticancer Res; 2005; 25(1B):509-14. PubMed ID: 15816620
[TBL] [Abstract][Full Text] [Related]
10. Human telomerase reverse transcriptase gene expression and the surgical management of suspicious thyroid tumors.
Umbricht CB; Conrad GT; Clark DP; Westra WH; Smith DC; Zahurak M; Saji M; Smallridge RC; Goodman S; Zeiger MA
Clin Cancer Res; 2004 Sep; 10(17):5762-8. PubMed ID: 15355904
[TBL] [Abstract][Full Text] [Related]
11. Morphometry in the cytologic evaluation of thyroid follicular lesions.
Nagashima T; Suzuki M; Oshida M; Hashimoto H; Yagata H; Shishikura T; Koda K; Nakajima N
Cancer; 1998 Apr; 84(2):115-8. PubMed ID: 9570215
[TBL] [Abstract][Full Text] [Related]
12. Telomerase activity in lesions of the thyroid: application to diagnosis of clinical samples including fine-needle aspirates.
Aogi K; Kitahara K; Buley I; Backdahl M; Tahara H; Sugino T; Tarin D; Goodison S
Clin Cancer Res; 1998 Aug; 4(8):1965-70. PubMed ID: 9717826
[TBL] [Abstract][Full Text] [Related]
13. Telomerase activity in thyroid malignancy.
Lo CY; Lam KY; Chan KT; Luk JM
Thyroid; 1999 Dec; 9(12):1215-20. PubMed ID: 10646661
[TBL] [Abstract][Full Text] [Related]
14. [Thyroid carcinoma and goiter: criteria for the differential diagnosis of benign and malignant nodules].
Pinchera A; Martino E; Siracusa G; Catarci A
Folia Endocrinol; 1966 Feb; 19(1):103-24. PubMed ID: 5953698
[No Abstract] [Full Text] [Related]
15. Serum cytokeratins determination in differentiated thyroid carcinoma.
Appetecchia M; Meçule A; Ducci M; Palma L; Castelli M
J Exp Clin Cancer Res; 2001 Jun; 20(2):253-6. PubMed ID: 11484983
[TBL] [Abstract][Full Text] [Related]
16. Telomerase activity in human thyroid carcinomas originating from the follicular cells.
Brousset P; Chaouche N; Leprat F; Branet-Brousset F; Trouette H; Zenou RC; Merlio JP; Delsol G
J Clin Endocrinol Metab; 1997 Dec; 82(12):4214-6. PubMed ID: 9398742
[TBL] [Abstract][Full Text] [Related]
17. [Clinical aspects and preoperative diagnosis in differentiated thyroid gland carcinoma].
Mann K; Schwetschenau B
Zentralbl Chir; 1997; 122(4):246-51. PubMed ID: 9221634
[TBL] [Abstract][Full Text] [Related]
18. Upregulation of HMGA2 in thyroid carcinomas: a novel molecular marker to distinguish between benign and malignant follicular neoplasias.
Belge G; Meyer A; Klemke M; Burchardt K; Stern C; Wosniok W; Loeschke S; Bullerdiek J
Genes Chromosomes Cancer; 2008 Jan; 47(1):56-63. PubMed ID: 17943974
[TBL] [Abstract][Full Text] [Related]
19. Differentiation of human follicular thyroid adenomas from carcinomas by gene expression profiling.
Zhao J; Leonard C; Gemsenjäger E; Heitz PU; Moch H; Odermatt B
Oncol Rep; 2008 Feb; 19(2):329-37. PubMed ID: 18202778
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic and prognostic value of angiogenesis-modulating genes in malignant thyroid neoplasms.
Kebebew E; Peng M; Reiff E; Duh QY; Clark OH; McMillan A
Surgery; 2005 Dec; 138(6):1102-9; discussion 1109-10. PubMed ID: 16360397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
